Biotoxtech Co., Ltd. (KOSDAQ:086040)
South Korea · Delayed Price · Currency is KRW 3,355.00
+105.00 (3.23%)
At close: Apr 24, 2026
Biotoxtech Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,163 | -6,427 | -4,878 | 2,725 | 7,114 |
Depreciation & Amortization | 4,333 | 4,098 | 3,679 | 1,945 | 1,672 |
Loss (Gain) From Sale of Assets | -2.68 | 22.86 | 3.75 | -1,969 | 209.58 |
Loss (Gain) From Sale of Investments | -8,030 | 1,242 | -12.64 | -1,310 | -2,273 |
Loss (Gain) on Equity Investments | 4.11 | 42.5 | 3.53 | -84.83 | -537.48 |
Stock-Based Compensation | 133.64 | 290.34 | 323.04 | 132.8 | 69.32 |
Provision & Write-off of Bad Debts | 384.58 | 1,073 | -220.68 | 1,514 | 101.89 |
Other Operating Activities | 2,285 | -909.53 | -4,831 | 3,495 | 701.78 |
Change in Accounts Receivable | -1,225 | -3,546 | 2,216 | -3,062 | -4,865 |
Change in Inventory | 7,511 | -2,887 | -7,498 | -3,794 | -56.21 |
Change in Accounts Payable | 14 | 131.74 | -241.56 | -32 | 693.57 |
Change in Unearned Revenue | 11.46 | - | - | - | - |
Change in Other Net Operating Assets | 55.73 | -250.6 | -4,781 | -867.74 | 1,516 |
Operating Cash Flow | 6,636 | -7,120 | -16,238 | -1,309 | 4,346 |
Operating Cash Flow Growth | - | - | - | - | -4.76% |
Capital Expenditures | -2,121 | -1,977 | -4,452 | -30,676 | -7,619 |
Sale of Property, Plant & Equipment | 24 | 0.53 | 24.35 | 92.32 | 8.02 |
Cash Acquisitions | - | - | - | -885.27 | -5,085 |
Divestitures | - | - | 499.85 | 8,250 | 1,873 |
Sale (Purchase) of Intangibles | -111.31 | -404.15 | -430.36 | -109.6 | -337.58 |
Investment in Securities | 10,866 | -8,435 | 3,525 | -3,580 | 3,842 |
Other Investing Activities | -875 | -125 | -1,145 | 26.97 | -408.83 |
Investing Cash Flow | 6,183 | -9,841 | -1,978 | -26,399 | -7,757 |
Short-Term Debt Issued | - | 2,000 | 18,100 | 6,040 | - |
Long-Term Debt Issued | - | 12,000 | 24,500 | 23,000 | 20,084 |
Total Debt Issued | - | 14,000 | 42,600 | 29,040 | 20,084 |
Short-Term Debt Repaid | -550 | -3,650 | -8,600 | -5,000 | -52.71 |
Long-Term Debt Repaid | -3,941 | -8,363 | -1,194 | -2,106 | -964.94 |
Total Debt Repaid | -4,491 | -12,013 | -9,794 | -7,106 | -1,018 |
Net Debt Issued (Repaid) | -4,491 | 1,987 | 32,806 | 21,934 | 19,066 |
Issuance of Common Stock | - | - | - | - | 393.12 |
Repurchase of Common Stock | -998.01 | -997.41 | - | - | - |
Other Financing Activities | - | -226.71 | 216.16 | -5.43 | -180.66 |
Financing Cash Flow | -5,489 | 762.48 | 33,022 | 21,929 | 19,279 |
Foreign Exchange Rate Adjustments | -68.04 | 89.32 | -26.16 | -113.35 | -23.05 |
Miscellaneous Cash Flow Adjustments | -0 | - | -0 | - | -0 |
Net Cash Flow | 7,262 | -16,109 | 14,779 | -5,892 | 15,845 |
Free Cash Flow | 4,515 | -9,097 | -20,691 | -31,985 | -3,273 |
Free Cash Flow Margin | 9.60% | -22.00% | -63.41% | -85.77% | -10.00% |
Free Cash Flow Per Share | 287.36 | -573.25 | -1341.02 | -2185.30 | -212.62 |
Cash Interest Paid | 1,661 | 2,016 | 1,851 | 835.52 | 413.22 |
Cash Income Tax Paid | 118.6 | 138.98 | 1,685 | 214.19 | 14.66 |
Levered Free Cash Flow | 46.31 | -7,681 | -10,757 | -28,440 | 1,922 |
Unlevered Free Cash Flow | 3,437 | -4,502 | -8,405 | -27,181 | 2,442 |
Change in Working Capital | 6,367 | -6,551 | -10,305 | -7,756 | -2,712 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.